Back to Search
Start Over
510-P: DKA Prevention on Insulin Pumps: Lessons Learned from a Large Pediatric Pump Practice
- Source :
- Diabetes. 71
- Publication Year :
- 2022
- Publisher :
- American Diabetes Association, 2022.
-
Abstract
- While the Type 1 Diabetes Exchange data noted that diabetic ketoacidosis (DKA) is more common in those utilizing injection regimens than insulin pumps, DKA remains a risk for pump users, as it can precipitously develop if insulin infusion is interrupted. We sought to obtain more recent DKA admission data in T1D youth using insulin pumps and the impact of CGM on DKA rates. Methods: We characterized DKA data in insulin pump users from episodes between 12/20 and 6/2021 in an academic pediatric endocrine practice in which 68% were pump users. Results: Among 591 pump patients aged Conclusions: DKA events were relatively uncommon; most episodes occurred in adolescents in poor diabetes control. Notably, most events could have been avoided if users followed standard trouble shooting guidelines. Thus, education on DKA prevention should be reinforced at each visit, particularly for teens on pumps with higher A1c levels. Moreover, while CGM wearers had higher admission bicarbonate values, over 50% of those hospitalized for DKA wore a CGM, suggesting even pump users using CGM require frequent reinforcement of DKA prevention education. Disclosure E.Doyle: None. S.A.Weinzimer: Consultant; Dompé, Research Support; Abbott Diabetes, Speaker's Bureau; Abbott Diabetes, Dexcom, Inc. W.V.Tamborlane: Consultant; AstraZeneca, Boehringer Ingelheim International GmbH, Medtronic, Novo Nordisk, Sanofi, Takeda Pharmaceutical Company Limited.
- Subjects :
- Endocrinology, Diabetes and Metabolism
Internal Medicine
Subjects
Details
- ISSN :
- 00121797
- Volume :
- 71
- Database :
- OpenAIRE
- Journal :
- Diabetes
- Accession number :
- edsair.doi...........b7e3e39d532ecd740804400fb8233ba1
- Full Text :
- https://doi.org/10.2337/db22-510-p